Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 13 of 13 for “"PD-1/PD-L1 Pathway"”.
-
The PD-1 / PD-L1 pathway: possible immunotherapeutic target in canine urothelial carcinoma
… pertaining to the programmed death ligand (PD-L1) and its receptor (PD-1). The present works evaluated three UC cell lines and documented protein and mRNA expression of both PD-1 and PD-L1 in all lines. In a group of canine patients with urothelial carcinoma, when compared to healthy control …
-
Expression of programmed death-1 (PD-1) and PD-1 ligands in human and murine tissue and their role in immunological tolerance: genetic, immunologic and immunohistochemical analysis of the PD-1/PD-L1 pathway in human systemic lupus erythematosus
… of T cell function. Programmed death-1 (PD-1) is an inhibitory lymphocyte receptor that has recently emerged as a key player in induction and maintenance of tolerance. Compared to other B7 receptors, PD-1 has a broader role in regulation of immune responses considering its expression on …
-
Gingival MSCs Improve Bone Phenotype in Ovariectomy-Induced Osteoporosis via Programmed Cell Death Pathway
… levels in recipient OVX mice. Mechanistically, PD-1/PD-L1 is a popular cellular death pathway being heavily investigated in multiple research fields, In our study, we found that GMSC expresses PD-L1 and that the improved bone phenotype resulting from the GMSC infusion was via the programmed cell …
-
Targeting IgV-like Domain Immune Checkpoint Receptors with Novel Nucleic Acid and Protein-Based Therapeutics
… is heavily regulated by negative checkpoint pathways; a network of cell signaling events governed by immune inhibitory ligand-receptor interactions. Physiologically, these negative checkpoint pathways are crucial for maintenance of self-tolerance in peripheral tissues. These pathways are …
-
Liquid biopsy-based T-cell receptor profiling in lung cancer patients undergoing immunotherapy
… and immune checkpoint inhibitors targeting the PD-1/PD-L1 pathway have significantly improved patient outcomes. However, only a subset of patients respond to treatment, highlighting the need for predictive biomarkers. The T-cell receptor (TCR) repertoire reflects the adaptive immune response and …
-
Novel Imaging-Based Techniques Reveal A Role For Pd-1/Pd-L1 In Tumor Immune Surveillance In The Lung
… immune inhibitory receptor Programmed Death 1 (PD-1) on T cells to its ligand PD-L1 has been implicated as a major contributor to tumor induced immune suppression. Clinical trials of PD-L1 blockade have proven effective in unleashing therapeutic anti-tumor immune responses in a subset of …
-
Μελέτη ανοσολογικών στοιχείων του νεοπλασματικού μικροπεριβάλλοντος στην ανάπτυξη και εξέλιξη του πλακώδους καρκινώματος του δέρματος
… The involvement of immune cells and the PD-1/PD-L1 pathway in the development of inSCC from precursors is still unclear. This study examines T cell populations, Langerhans cells and PD-L1 expression in inSCC, adjacent precursors and normal skin (NS) to investigate their possible …
-
Η κλινική σημασία των ανοσοϋποδοχέων PD σε ασθενείς με διάχυτα λεμφώματα από μεγάλα B κύτταρα: συσχέτιση με κλινικά και παθολογοανατομικά ευρήματα των ασθενών
… of lymphocytes, programmed cell death-1 (PD-1), plays an inhibitory role in the proliferation and activation of T lymphocytes and, therefore, in the immune surveillance and destruction of neoplastic cells through its binding to 2 ligands, PD-L1 (CD274 or B7-H1) and PD-L2 (CD273 or B7-DC). …
-
Exploring multivalency and chemical modifications in the development of anti-PD-L1 peptide inhibitors for cancer immunotherapy
The PD-1/PD-L1 immune checkpoint axis is one of the most common pathways exploited by cancers to evade immune surveillance. Many cancers overexpress PD-L1 (programmed cell death ligand 1) on their surface through which they interact with PD-1 (programmed cell death protein 1) on activated immune …
-
Programmed cell death-ligand 1 (PD-L1) expression in HIV-associated diffuse large B-cell lymphoma – role and regulation
… programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) signalling pathway is an important immunoregulatory mechanism that dampens the immune response by inhibiting T cell activity, playing a central role in controlling and maintaining tolerance to self-antigens. However, cancer cells have …
-
Prostate cancer, radiotherapy and immune response
… One of the best studied immune escape pathways exploited by cancer cells is the PD-L1/PD-1 immune checkpoint pathway, which the major target we investigated in this PhD thesis. At the same time, we aimed to study the effect of different radiation therapy regimens on the Type I …